產(chǎn)品名稱 | 磷酸化Bcl-xL蛋白抗體 |
英文名稱 | Anti-phospho-Bcl-xL/BCL2L1(Thr47) |
規(guī)格 | 0.1ml/100μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-phospho-Bcl-xL/BCL2L1(Thr47)
中文名稱 磷酸化Bcl-xL蛋白抗體
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Cow, Horse, Sheep, Guinea Pig
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 腫瘤 細(xì)胞生物 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 新陳代謝 線粒體
蛋白分子量 predicted molecular weight: 26kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derivedfrom human BCL2L1 around the phosphorylation site of Thr47
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1%BSA, 0.01M PBS, pH 7.4
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -32 °C for oneyear.
別 名 BCL2L1 (phospho T47); BCL2L1 (phospho Thr47);p-BCL2L1 (phospho T47); p-BCL2L1 (Thr47); p-BCL2L1(Thr115); Apoptosis regulatorBcl X; BclX; Bcl-X; Bcl 2 like 1; Bcl 2 like 1 protein; Bcl xL; BCL X/L; BCLXL/S; Bcl xS; Bcl2 like1; BCL2-related gene; BCL2-related protein, longisoform, included; BCLXL, included; BCL2-related protein, short isoform,included; BCLXS, included; BCL2L; BCL2L1; Bclx; DKFZp781P2092; MGC113803;MGC99998; B2CL1_HUMAN.
